CLDX SG&A Expense Growth
Celldex Therapeutics Inc · SG&A Expense Growth
CLDX SG&A Expense Growth
Latest reported13.62%period ending
CLDX FY SG&A Growth (YoY) (0.00% → 13.62%)
Latest values, visible window
High-resolution chart · PNG
CLDX sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 13.6246% | |
| 24.6943% | |
| 13.6753% | |
| 32.7362% | |
| 41.7266% | |
| -6.2881% | |
| -19.944% | |
| -22.9332% | |
| -30.5067% | |
| 6.3303% | |
| 64.082% | |
| 39.2908% | |
| 47.8135% | |
| 8.3631% | |
| -11.3636% | |
| -39.0852% | |
| 16.0815% | |
| 73.4601% | |
| 3.2177% | |
| 19.4621% | |
| 23.7428% | |
| 4.1398% | |
| -4.3204% | |
| 13.797% | |
| 2.2004% | |
| 12.3382% | |
| 12.6368% | |
| 8.5714% | |
| -46.1538% | |
| 10.1695% | |
| 1.7241% | |
| -63.75% | |
| 58.4158% | |
| -21.7054% | |
| 12.1739% | |
| 38.5542% | |
| 36.0656% | |
| 64.8649% | |
| 94.7368% | |
| 0% |